The pharmaceutical company Pfizer has agreed to pay $450 million to Brigham Young University to settle a lawsuit over the drug Celebrex, The Deseret News reported. Brigham Young and one of its professors have accused the company of unfairly using his work conducted at the university for the drug. The announcement of the settlement did not detail terms, but a footnote in a quarterly report issued by Pfizer references a $450 million expense related to the Brigham Young suit.
- Quick Takes: Divisions on Gallaudet Board, Students Don't Worry About Professorial Rank, Brigham Young Sues Pfizer, Sociologists Back Evolution, James Madison Parents Complain to NCAA, Eccentric's Art Was Stolen From Harvard, Disputed Study Published
- Drug Warnings Could Protect Students, Too
- A lawsuit filed against two labs founded by UT-Austin professor raises questions of conflict of interest and academic freedom
- 2 Companies Will Pay Emory $525 Million for Drug Royalties
- Ethics and Patents
Search for Jobs
Popular Job Categories